期刊文献+

人骨桥蛋白表达载体的构建及其在大肠杆菌中的表达 被引量:2

Construction of pGEX-6P- human osteopontin and its expression in E. coli XL1-blue
下载PDF
导出
摘要 目的 构建人骨桥蛋白 (hOPN)表达载体 ,体外表达及表达产物的纯化。方法 培养人脐静脉内皮细胞 ,提取总RNA ,反转录合成cDNA第一链 ,以此cDNA为模板经PCR合成插入片段 ,连接至载体 pGEX 6P 1,转化到XL1 blue中进行诱导表达。表达产物经SDS 聚丙烯酰胺凝胶电泳后 ,切下目的蛋白进行洗脱纯化。结果 构建的表达载体经限制性内切酶酶切图谱分析和DNA测序 ,证明所构建的质粒是 pGEX 6P OPN。SDS 聚丙烯酰胺凝胶电泳发现该重组质粒经IPTG诱导后表达一种新的蛋白 (表达量为 16 7% ) ,这种蛋白不存在于诱导后的pGEX 6P 1表达产物中 ,纯化后蛋白纯度为 99%。结论 成功构建了hOPN表达载体 ,并进行体外表达。 Objective To construct the recombinant vector pGEX-6P-human osteopontin and express the recombinant protein in Escherichia coli. Methods First, cell culture was used to prepare total RNA; Second, the first chain of cDNA was synthesized using RT-PCR; Third,PCR was used to amplify human osteopontin segment, which was inserted into pGEX-6P-1 to construct expression vector; Then the recombinant vector was transformed into XL1-blue and expressed by adding IPTG; and finally, the expression product was purified from the gel after SDS-PAGE. Results Restriction endonucleases mapping analysis and DNA sequencing demonstrated that the constructed plasmid was the recombinant pGEX-6P-opn. The recombinant vector expressed a new protein which didn't present in pGEX-6P-1. Conclusion Construction and expression of hOPN were successful.
出处 《安徽医科大学学报》 CAS 2002年第6期419-422,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金 ( 0 10 43716和 990 44312 ) 国家自然科学基金 ( 39870 32 4)资助
关键词 大肠杆菌 表达 聚合酶链反应 基因表达 骨桥蛋白 polymerase chain reaction gene expression
  • 相关文献

参考文献14

  • 1O' Reagan AW, Berma JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Path, 2000; 81(6):373~390
  • 2Ashkar S, Weber GF, Panoutsakopoulou V et al. Eta-1 (Osteopontin): An early component of type-1 (cell-mediated) immunity.Science, 2000; 287 (5454): 860~864
  • 3Lin YH, Yang-Yen HF. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem, 2001; 276(49):46024~46030
  • 4Helluint O, Chun C, Vilaire G et al. The activation state of αvβ3regulates platelet and lymphocyte adhesion to intact and thrombincleaved osteopontin. J Biol Chem,2000; 275(24):18337~18343
  • 5Bayless KJ, Davis GE. Identification of dual alpha 4betal integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J Biol Chem, 2001 ;276(16):13483~13489
  • 6Denhardt DT, Giachelli CM, Rittling SR et al. Role of osteopontin in celluar signaling and toxicant injury. Annu Rev Pharmacol Toxicol, 2001 ;41:723~749
  • 7Denhardt DT, Noda M, O'Regan AW et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation , tissue remodeling, and cell surivival. J Clini Investigation,2001; 107 (9): 1055~1061
  • 8Yasuyuki Yokosaki, Nariaki Matsuura, Tomohiro Sasaki et al. The Integrin α9β1 Binds to a Novel Recognition Sequence(SVVYGLR)in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin.J Biol Chem , 1999; 274(51) :36328~36334
  • 9Smith LL, Cheng HK, Ling LE et al. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by α9β1 integrin. J Biol Cherm, 1996; 271(46) :28485~28491
  • 10Dana DH, John RH, Jeffrey WS et al. Ca2+ Suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin αvβ3. J Biol Chem , 1995;270(17) :9917~9925

共引文献6

同被引文献14

  • 1Shoemaker MO, Lau W, Shattuck RL et al. Use of DNA sequence and mutant analysis and antisense o ligodeoxynucleo tides to exam ine the molecular basis of nonmuscle myo sin light chain kinase auto inhibition, calmodulin recognization and activity. J Cell Biol, 1990; 111(3): 1107~25
  • 2萨姆布鲁克 J, 弗里奇 EF, 曼尼阿蒂斯T. 分子克隆实验指南(第3版).北京:科学出版社, 2002; 1217-35
  • 3Rosenberg AH, Lade BN, Chui DS et al. Vetors for selective expression of cloned DNAs by T7 RNA polymerase. Gene, 1987;56(1):125~35
  • 4Lee CA, Beckwith J. Suppression of growth and protein secretion defects in Escherichia coli secA mutants by decreasing protein synthesis. J Bacteriol, 1986;166(3):878~83
  • 5Kopetzki E, Schhumacher G, Buckel P.Contol of formation of active soluble or inactive insoluble bakers yeast aglucosidase PI in Escherichia coli: by induction and growth condition. Mol Gen Genet, 1989; 216(1):149~15
  • 6Lavallie ER, McCoy M. Gene fusion expression systems in Escherichie coli. Curr Opin Biotechnol, 1995;6(5):501~6
  • 7Yeatman TJ, Chambers AF. Osteopontin and colon cancer progression. Clin Exp Metastasis, 2003;20(1): 85~90.
  • 8Guo XZ, Friess H, Grber HU et al. KAⅡis up-regulated in early pancreatic cancer and decreased in the presense of metastases. Cancer Res,1996;56(21):4876~80.
  • 9Craig AM, Bowden GT, Chambers AF et al. Secreted phosphoproteinmRNA is induced during multi-stage carcinogenesis in mouse skin andcorrlelates with the metastatic potential of murine fibroblasts. Int J Cancer, 1990; 46(1) :133~7.
  • 10Tuck AB, Arsenault DM, O′Malley FP et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene, 1999;18(29): 4237~46.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部